80 likes | 101 Views
Prequalification of Quality Control Laboratories WHO Quality Monitoring Projects. Tony Gould for Jitka Sabartova Prequalification of Medicines Programme WHO. QCLs Prequalification Procedure. Established in 2004 - for QC laboratories in Africa only
E N D
Prequalification of Quality Control LaboratoriesWHO Quality Monitoring Projects Tony Gould for Jitka Sabartova Prequalification of Medicines Programme WHO
QCLs Prequalification Procedure • Established in 2004 - for QC laboratories in Africa only • 3rd Invitation for Expression of Interest published in September 2007 • Without regional limitation • http://www.who.int/prequal/info_applicants/eoi/EOI-QCLabsV3.pdf • Participation of a QC laboratory is voluntary • Any laboratory (private or governmental) can participate • Free of charge • Published list of prequalified laboratories • The list may be used by any organization to ensure that testing for quality monitoring is done at an acceptable standard Technical Briefing Seminar, 1-5 November 2010
Prequalified / interested laboratories (1) October 2010 Prequalified QCLs: • South Africa, RIIP+CENQAM (2005) • Algeria, LNCPP (2005) • South Africa, Adcock Ingram (2007) • Morocco, LNCM (2008) • Kenya, NQCL (2008) • India, Vimta Labs (2008) • France, CHMP (2008) • Vietnam, NIDQC (2008) • Kenya, MEDS (2009) • Singapore, HSA (2009) • Singapore, TÜV (2009) • Canada, K.A.B.S. Laboratories (2010) • Ukraine, CLQCM (2010) • Ukraine, LPA (2010) • Peru, CNCC (2010) • Uruguay, CCCM (2010) • Bolivia CONCAMYT (2010) Technical Briefing Seminar, 1-5 November 2010
Monitoring the quality of medicines • Policy • To monitor quality of medicines procured by UN agencies/ prequalified products • To contribute to quality control of medicines, if requested by Member States • To contribute to capacity building by cooperation with NDRAs • Sampling and testing projects • Planned and implemented according to protocols • WHO prequalified laboratories used, if possible Technical Briefing Seminar, 1-5 November 2010
Quality survey of antimalarials(QAMSA - 2008/9) • ACTs (most sold and recommended by national guidelines), sulfadoxine-pyrimethamine, oral dosage forms • Artemether/lumefantrine, artesunate/amodiaquine (both co-blistered and FDCs), sulfadoxine/pyrimethamine, sulfamethoxypyrazine/pyrimethamine • In 6 African countries (Cameroon, Ethiopia, Ghana, Kenya, Nigeria, Tanzania) • Collection of samples • By NDRAs in cooperation of with WHO country offices • At all levels of distribution chain (private and public) and informal market, throughout the countries • Testing • 935 samples collected and screened by GPHF-Minilab • 306 selected for testing in QC laboratory (RIIP, South Africa; USP laboratory) according to Ph.Int., USP, laboratory in-house method Technical Briefing Seminar, 1-5 November 2010
QAMSA - Failure rates by product Technical Briefing Seminar, 1-5 November 2010
QAMSA - comparison of failure rates of prequalified and non-prequalified products AL: arthemether/ lumefantrine AA: artesunate/ amodiaquine Technical Briefing Seminar, 1-5 November 2010
Thanks for your attention prequallaboratories@who.int www.who.int/prequal Technical Briefing Seminar, 1-5 November 2010